Research collaboration identifies biomarker panel linked to melanoma patient survival

June 6, 2017, University College Dublin
Melanoma. Credit: UCD Conway

An international research collaboration led by University College Dublin (UCD), involving the UCD spin-out company OncoMark and Bellvitge Biomedical Research Institute in Barcelona, has identified a set of biomarkers strongly linked with survival in patients with melanoma that may help clinicians with treatment decisions.

The study has also identified several biomarkers of tumour development and progression that have never been linked to cutaneous until now.

Cutaneous melanoma is the most life-threatening form of skin cancer with rising incidence and mortality rates particularly in men over 55 years and women of all ages.

Currently, there are very limited tools available to help clinicians pinpoint the stage of the disease in a patient at the time of diagnosis. Clinicians make their diagnosis based on classical identifiers such as the thickness of the tumour.

Up until now, it has been problematic to identify early events during the development and progression of melanoma as studies used samples from tumour metastases rather than the primary tumour.

This study involved a comprehensive mapping of the extent of DNA methylation occurring at three distinct stages of development of this skin cancer; from benign nevi to malignant melanoma to metastatic melanoma.

DNA methylation is a natural chemical change that results in genes being switched on or off. This epigenetic change does not alter the genetic code itself but affects how genes are read by cells and what proteins are made as a result.

The team have shown the importance of epigenomic regulation in triggering tumour spread by the way in which it can switch off certain cancer-related pathways and interrupt normal cell processes such as cell adhesion. When this occurs, can break away from each other and metastasise or travel away from the original location to other parts of the body.

Describing the significance of this study, Professor William Gallagher, UCD Professor of Cancer Biology at the UCD Conway Institute and Chief Scientific Officer at OncoMark said,

"This research highlights that this type of comprehensive, genome-wide DNA methylation mapping can provide insight to the transformation and aggressiveness of tumour cells. It has allowed us to identify a DNA methylation signature associated with patient survival and we are excited by the potential clinical utility of these biomarkers. They may provide clinicians with a powerful tool to stratify who have benign versus more aggressive types and allow them to tailor treatment accordingly."

According to Dr Manel Esteller (Bellvitge Biomedical Research Institute, Barcelona), co-lead author on the study:

"This study represents the most comprehensive epigenomic profiling assessment of well-described human melanomas. It verifies that DNA methylation biomarkers represent a valuable tool to identify potential protein biomarkers. This not only has implications for the clinical management of melanoma but several cancer types."

Dr Jasper Wooters, first author of the study, says,

"In this epigenomic melanoma study, we establish novel biomarkers to identify patients with good prognosis that do not necessarily need to undergo aggressive and expensive therapies. Importantly, some of these biomarkers can potentially be assessed non-invasively, using cell-free DNA in the serum of patients."

Explore further: A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented

More information: Jasper Wouters et al. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma, BMC Medicine (2017). DOI: 10.1186/s12916-017-0851-3

Related Stories

A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented

February 19, 2014
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection ...

Epigenomic changes play an important role during the progression of melanoma

April 9, 2015
KU Leuven researchers have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures. Melanoma, a type of skin cancer, is notoriously quick to metastasize and ...

A protein that defines the melanoma blueprint

November 18, 2016
The main goals of the Melanoma Group at the Spanish National Cancer Research Centre (CNIO) are to identify biomarkers of tumour progression and to validate novel therapeutic targets in melanoma. In particular, their research ...

Study reveals how melanoma spreads

February 8, 2017
Cancerous tumors are voracious. Once they have consumed all the oxygen and nutrients in the original tumor site, the cancer cells travel to other parts of the body (metastasize) to find more nourishment.

Melanoma research breakthrough gives hope for treatment

February 7, 2017
A QUT-driven project has identified the way in which melanoma cells spread, opening up new pathways to treatment via drugs to 'turn off' the invasive gene.

Recommended for you

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Protein can slow intestinal tumor growth

April 19, 2018
A new mechanism for regulating stem cells in the intestine of fruit flies has been discovered by researchers at Stockholm University. In addition, it was discovered that a certain protein can slow the growth of tumours in ...

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

April 19, 2018
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary diagnosis, and even though chemotherapy can be effective as standard-of-care, many ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.